AADYIXX

ETF / Mutual Fund
NASDAQ
HSBC Bank USA, N.A. Autocallable Step Up Point to Point CD AADYIXX
Price Chart
Overview

About AADYIXX

A clinical-stage biopharmaceutical company focusing on developing transcription factor decoy technologies for treating pain and inflammatory diseases. Their pipeline includes brivoligide in Phase II for postoperative pain and AYX2 in pre-clinical development for focal chronic pain.

AUM
Volume
Avg. Volume
Expense Ratio

Top Holdings

Other
100.00%

Sector Allocation

Other100.00%

Country Allocation

Other100.00%

Fund Information

Exchange
NASDAQ
Sector
Latest News for AADYIXX
Risk & Correlation Analysis
Market Correlation
0.00
Low Correlation
Volatility
Low (0.00)
Relative to market
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for AADYIXX.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, AADYIXX shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
AUM
Volume
Expense Ratio
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how AADYIXX fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025